Atlas Trials

Use of Galantamine and CDP-choline (Citicoline) to Treat Adults With Schizophrenia

Clinical trial NCT00509067 · COMPLETED

Trial details

NCT number
NCT00509067
Sponsor
Georgetown University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2007-11-01
Primary completion
2011-03-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.